Navigation Links
Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Date:9/26/2007

ASHBURN, Va., Sept. 26 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced the following status and progress updates regarding its clinical development programs and specialty pharmaceutical operations:

- Three Investigational New Drug (IND) Applications already approved

in 2007.

- GENTAMICIN SURGICAL IMPLANT to commence two US phase 3 multi-centered

clinical trials for the prevention of surgical site infection.

- CollaRx(R) GENTAMICIN TOPICAL to commence a series of phase 2 clinical

trials for the treatment and prevention of infected diabetic foot

ulcers.

- BUPIVACAINE SURGICAL IMPLANT to commence a series of phase 2 clinical

trials for the management of post-operative pain in a variety of soft

tissue and orthopedic surgery models.

- First patient dosing in at least five different clinical trials (three

in phase 2 and two in phase 3) expected before the end of 2007.

- IND submission planned for CollaRx(R) BUPIVACAINE TOPICAL, a new product

opportunity for the management of painful chronic and acute wounds.

- US Launch of CollaGUARD(TM), an advanced wound care product developed by

Innocoll and its first to be launched in the US, is planned for the

fourth quarter 2007.

- European sales and marketing infrastructure sold to EUSA Pharma in

August 2007.

Commenting on the update, Dr. Michael Myers, President and CEO of Innocoll Inc., said, "Our successes over the past few months have established a solid platform on which to build the future growth of the business. We are looking forward to the launch of our first product in the US with CollaGUARD and are poised to commence the clinical development of an exciting portfolio of late- stage pharmaceutical products. According to recent market research performed by L.E.K. Consulting, these three products between them have projected ann
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. XTL Provides Update on Phase I Clinical Trial of XTL-2125
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
7. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
8. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
9. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:7/10/2014)... News) -- Teens who are sensitive to light or ... emotional symptoms such as anxiety and depression, a new ... may exacerbate issues teens experience after concussion may help ... decisions about when to return to play and what ... authors Lisa Koehl and Dong Han, of the University ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 (HealthDay ... regularly between outspoken celebrities or loudmouth pundits -- too much ... study suggests. High amounts of Twitter use can lead ... in a long-term relationship, according to findings from an online ... can lead to cheating and breakups, the researchers concluded, although ...
(Date:7/10/2014)... responders felt better prepared to respond to an active ... a new study in the journal Prehospital and ... specifically examine the EMS provider comfort level with respect ... yet been neutralized or working with law enforcement personnel ... High School shooting, the Virginia Tech campus shooting, the ...
(Date:7/10/2014)... PHILADELPHIA Reducing the amount of alcoholic beverages ... health, including a reduced risk of coronary heart ... pressure, according to a new multi-center study published ... the Perelman School of Medicine at the University ... previous studies which suggest that consuming light-to-moderate amounts ...
(Date:7/10/2014)... Department of Health and Human Services (HHS) has announced ... Center Seidman Cancer Center totaling $4.7 million to support ... patients with complex cancer. , Titled "Evidence-Conformant Oncology ... at UH to enhance care for adult cancer patients ... high health care utilization. , "We believe ...
Breaking Medicine News(10 mins):Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:New study shows drinking alcohol provides no heart health benefit 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... 17 (HealthDay News) -- Children with bipolar disorder and ... time looking at the eyes when trying to identify ... researchers say. This new study finding may help ... dysregulation have difficulty determining other people,s emotional expressions, said ...
... 17, 2011 -- Factors such as low hemoglobin levels, increased ... higher risk of silent cerebral infarcts (SCIs), or silent strokes, ... from a large, first-of-its-kind study published online today ... the American Society of Hematology (ASH). Silent strokes ...
... (HealthDay News) -- Most people who join gangs have ... that challenges previous research suggesting gang membership is driven ... an antisocial personality are impulsive, lack self-discipline and self-control, ... this, they may be excluded from groups at school ...
... increasingly common, and a dangerous lack of new infection ... than ever to use existing antibiotics appropriately. This week, ... care providers, and policymakers about when antibiotics can help, ... harm than good, and the tremendous need for new ...
... that keep blood vessels open to treat heart disease ... in the Journal of Interventional Cardiology . A ... Grines, of the Detroit Medical Center Cardiovascular Institute, and ... attack after the recently marketed Ion stent (Boston Scientific, ...
... InDevR, a Boulder-based biotechnology company that develops advanced ... viruses and other microorganisms, announced today the launch ... colorimetric detection system that incorporates core technology licensed ... will enhance laboratories around the world by offering ...
Cached Medicine News:Health News:Bipolar Kids May Focus on Different Facial Features 2Health News:Study identifies 'silent' stroke risk factors for children with sickle cell anemia 2Health News:Preserving lifesaving antibiotics today and for the future 2Health News:Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU 2
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
DMSO-resistant microplate sealing film...
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Aluminum Seal, Reflective, Bulk...
Medicine Products: